Skip to main content
. 2020 Jul 7;10:11133. doi: 10.1038/s41598-020-67814-9

Figure 2.

Figure 2

iKras*p53* PDAC cells recapitulate oncogenic Kras* effector pathway activation and expression of membrane proteins in vitro. (a) Nuclear visualization with DAPI along with staining for phosphorylated ERK (pERK) species, indicating MAPK activity in primary tumors and iKras*p53* PDAC cells grown in 3D culture for 6 days. Scale bar 50 µm. (b) Nuclear visualization along with staining for phosphorylated S6 ribosomal protein (pS6) in primary tumors and PDAC cells in 3D culture. (c–j) DAPI staining along with visualization of membrane proteins e-cadherin and claudin-18 in primary tumor and PDAC cells in 3D culture.